InsiderTrades

Form 4 for INSM INSMED Inc

Accepted 2024-01-02 00:00:00 ET · period of report 2023-12-28 · accession 0001628280-24-000052 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-01-02 2023-12-28 INSM Schaeffer Orlov S Nicole Chief People Strategy Off M - OptEx $20.49 +22.3K 116.8K +24% +$456.7K
D 2024-01-02 2023-12-28 INSM Schaeffer Orlov S Nicole Chief People Strategy Off S - Sale+OE $32.00 -22.3K 94.5K -19% -$713.2K
D 2024-01-02 2023-12-28 INSM Schaeffer Orlov S Nicole Chief People Strategy Off M - OptEx $0.00 -22.3K 503 -98% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-12-28 M A 22,288 $20.49 116,837 D — — (F2) Includes 1,024 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
2 Common Common Stock 2023-12-28 S D 22,288 $32.00 94,549 D — —
3 Derivative Stock Option (right to buy) 2023-12-28 M D 22,288 $0.00 503 D $20.49 · — to 2024-01-04 22,288 Common Stock (F3) Stock options granted under the Company's 2013 Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.